| LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 |
601 PENNSYLVANIA AVENUE, NW
| Address2 |
SUITE 700
|
| City |
WASHINGTON, DC
| State |
DC
| Zip Code |
20004
| Country |
USA
|
3. Principal place of business (if different than line 2)
| City |
Franklin Lakes
| State |
NJ
| Zip Code |
07417
| Country |
USA
|
| 5. Senate ID# 89177-12
|
||||||||
| 6. House ID# 366750000
|
||||||||
| TYPE OF REPORT | 8. Year |
2011
| Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
| 11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income from the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
| Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature |
Digitally Signed By: Peter Harty, Vice President, Government Affairs
| Date |
07/20/2011
|
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Issues related to Healthcare Reform Act implementation: Health Information Technology; ARRA Privacy and Security Rules; Generic Biologics; Importation of Prescription Drugs; Competitive Bidding; Home Infusion; Chronic Care Management; Anti-PBM legislation, including disclosure of pricing and contracting information; healthcare delivery system reforms; and cost containment
H.R. 1 - American Recovery and Reinvestment Act of 2009; Title VIII Department of Labor, Health and Human Services, and Education, and related agencies; Healthcare Research and Quality and Title XIII - Health Information Technology for Economic and Clinical Health Act or the HITECH Act; all sections
H.R. 1548 - Pathway for Biosimilars Act; all sections
H.R. 3200 - America's Affordable Health Choices Act; all sections
Public Law 111-148 - Patient Protection and Affordable Care Act ("Affordable Care Act"); all sections (formerly H.R. 3590, H.Con.Res. 254, S. 1790)
Public Law 111-152 - Healthcare and Education Recociliation Act of 2010; all sections (formerly H.R. 4872 and S.Con.Res. 13)
H.R 979 - The FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act; all sections
H.R. 1041 - Fairness in Medicare Bidding Act (FIMBA); section 2
H.R. 5 - Help Efficient, Accessible, Low Cost, Timely Healthcare (HEALTH) Act of 2011; all sections
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Federal Trade Commission (FTC), Food & Drug Administration (FDA), Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
|
Peter
|
Harty
|
|
| |
|
Lillian
|
German
|
|
| |
|
Ryan
|
Sadler
|
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Healthcare reform proposals that impact Medicare Part D; healthcare regulations; Closing of the Part D coverage gap; proposed antitrust exemptions for certain pharmacies; IVIG payments; Medicare demonstration projects for durable medical equipment; importation of prescription drugs; home infusion; PBM disclosure provisions; changes to drug benefits offered under the FEHBP and increasing healthcare value; competitive bidding
H.R. 2195 and S. 1203 - Medicare Home Infusion Therapy Coverage Act; all sections
H.R. 3962 - Affordable Care for All Americans; all sections
H.R. 1845 and S. 960 - To Amend Title XVIII of the Social Security Act with respect to payment for the furnishing of intravenous immunoglobulin (IVIG) in a patient's home for the treatment of primary immune deficiency diseases and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program; all sections
H.R. 1041 - Fairness in Medicare Bidding Act; all sections
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
|
Peter
|
Harty
|
|
| |
|
Lillian
|
German
|
|
| |
|
Ryan
|
Sadler
|
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit; Electronic prescribing; PBM disclosure requirements; medical loss ratio; legislation to promote generic drugs; regulatory implementation of a pathway for the approval of biosimilars; 340(b) program
H.R. 1 - American Recovery and Reinvestment Act of 2009; Title XIII - Health Information Technology for Economic and Clinical Health Act or the HITECH Act; all sections
H.R. 979 - The FEHBP Drug Integrity, Transparency, and Cost Savings Act of 2011; all sections
S. 27 - Preserve Access to Affordable Generics Act; all sections
S. 1058 - Transparency and Proper Operation of Pharmacy Benefits Managers Act; all sections
H.R. 1041 - Fairness in Medicare Bidding Act; all sections
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Government Accountability Office (GAO), Health & Human Services - Dept of (HHS), Congressional Budget Office (CBO)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
|
Peter
|
Harty
|
|
| |
|
Lillian
|
German
|
|
| |
|
Ryan
|
Sadler
|
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code POS
16. Specific lobbying issues
Legislation related to proposals to limit mail delivery service by the United States Postal Service; postal reform
H.R. 1262 - Reform the Postal Service for the 21st Century Act; all sections
H.R. 2309 - Postal Reform Act; all sections
H.Res. 137 - Expressing the Sense of the House of Representatives that the United States Postal Service should take all appropriate measures to ensure the continuation of its 6-day mail delivery system
H.R. 1351 - United States Postal Service Pension Obligation Recalculation and Restoration Act of 2011; all sections
S. 353 - United States Postal Service Improvements Act of 2011; all sections
S. 1010 - United States Postal Service Improvements Act of 2011; all sections
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Government Accountability Office (GAO), Postal Regulatory Commission
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
|
Peter
|
Harty
|
|
| |
|
Lillian
|
German
|
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
| State |
| Zip Code |
| Country |
|
21. Client new principal place of business (if different than line 20)
| City |
| State |
| Zip Code |
| Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
| 5 |
|
||||||
| 2 |
| 6 |
|
||||||
| 3 |
| 7 |
|
||||||
| 4 |
| 8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
|
||||||||||||||
| Accredo Health Group, Inc. |
|
|
||||||||||||
| Liberty Medical Supply, Inc. |
|
|
||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 3 | 5 |
| 2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address | Principal place of business (city and state or country) | Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
|
||||||||||||||
|
|
| % | ||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 5 | 9 |
| 2 | 6 | 10 |
| 3 | 7 | 11 |
| 4 | 8 | 12 |